Medicare:

Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy

PEMD-92-28: Published: Jul 17, 1992. Publicly Released: Aug 17, 1992.

Additional Materials:

Contact:

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

Pursuant to a congressional request, GAO examined factors that influence where oncologists treat Medicare patients and the potential cost to the federal government of treatment in different settings.

GAO found that: (1) some oncologists have treated cancer patients in hospital inpatient and outpatient settings when, by clinical standards, these patients could have received treatment in the office; (2) oncologists interviewed consistently stated that their choice of treatment setting was influenced by whether they expected reimbursement to be adequate if they provided treatment in the office setting; and (3) treatment in the hospital inpatient setting was more expensive to Medicare than hospital outpatient or office treatment settings.

Nov 13, 2018

Oct 30, 2018

Oct 23, 2018

Oct 15, 2018

Oct 1, 2018

Sep 28, 2018

Sep 17, 2018

Sep 13, 2018

Sep 10, 2018

Sep 6, 2018

Looking for more? Browse all our products here